Scleroderma Support: Patients Find Help Online

A new website is helping patients with scleroderma learn more about the condition, how to manage their symptoms and self-advocacy strategies.

2:52 PM

Author | Helen Korneffel

Scleroderma is a rare autoimmune disease, affecting about 300,000 Americans, but for those it affects it can be challenging to manage.

The disease is associated with chronic inflammation and fibrosis in the connective tissues and visibly results in hardening and tightening of the skin, among other symptoms. Depending on the severity, patients can also experience issues with internal organs.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunesGoogle Play and Stitcher.

"When patients are first diagnosed with scleroderma, they go to the internet for information about what is happening to their bodies," says Dinesh Khanna, M.D., M.Sc., a professor of rheumatology and the director of the Michigan Medicine Scleroderma Program.

"The majority of that information is too broad to apply to a specific patient, or simply inaccurate."

That's why Khanna collaborated with the University of New Mexico School of Medicine, the Scleroderma Foundation, the Scleroderma Research Foundation, and with funding from the Patient-Centered Outcomes Research Institute, created an interactive website specifically for scleroderma patients.

The website, titled Self-Manage Scleroderma, provides patients with information on the condition, how to manage their symptoms and self-advocacy strategies they can implement in their everyday lives.

Our goal is to appropriately educate patients on different techniques to help them manage the challenges that arise from having a scleroderma diagnosis.
Dinesh Khanna, M.D., M.Sc.

Patients begin accessing the website by filling out a quick survey on the website's main page. Upon completion, they are able to explore the site for information they find specifically useful in helping them manage their condition.

"Our website was created to provide essential information to patients in one, scientifically accurate place," Khanna says.

Support for scleroderma patients anywhere

He notes that because of the collaboration effort amongst the different organizations, the website can be used by scleroderma patients across the world, not just patients he sees at Michigan Medicine.

"Here at Michigan Medicine, we are providing an exceptional, multi-disciplinary care program, and we are striving to help current and future scleroderma patients," Khanna says.

"But for those scleroderma patients who live in states where there is no chapter of the Scleroderma Foundation or no support groups available in a certain community, this website provides virtual support and allows them to see what lays ahead of them."

He also recommends the website to his own patients he sees in clinic.

"A scleroderma diagnosis can be difficult for my patients emotionally, as it does affect a person's appearance," Khanna says. "When patients are worried about their diagnosis, we can now direct them to the website for more information that may be specifically helpful to them."

Future knowledge

Khanna and the Michigan Medicine Scleroderma Program team will continue the translational work happening between their laboratories and clinics in order to better understand scleroderma, and hope to keep the Self-Manage Scleroderma website up-to-date with their latest findings.

"Autoimmune diseases are very complex because they each have different genetic backgrounds and have unknown triggers," Khanna says. "The work being done at Michigan Medicine to understand this multi-faceted disease [scleroderma] is expanding every year."

He hopes that with time, more and more people will sign-up for the website and are able to gather information and advice.

"Our goal is to appropriately educate patients on different techniques to help them manage the challenges that arise from having a scleroderma diagnosis," Khanna says.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

"This is a platform that captures everything patients need to know to help them function as healthy, happy and informed individuals."

If you are a patient with scleroderma, please visit the Self-Manage Scleroderma website for more information or the Michigan Medicine Scleroderma Program website. The Michigan Medicine Scleroderma Program also offers patients a Peer Mentoring Program to provide patients hope, encouragement and understanding. To learn more, please visit the Peer Mentors for Scleroderma webpage.  


More Articles About: Health Management Rheumatology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories friends hugging purple butterflies
Health Lab
Lupus: A frustrating diagnosis journey you don’t need to embark alone
Nicknamed the “invisible disease”, the autoimmune disorder comes with lifestyle changes that can be a challenging adjustment.
man hatting tennis ball
Health Lab
His shortness of breath signaled a deeper, underlying issue
A rare autoimmune disease, myositis, caused one man to need a double lung transplant. Now that he’s recovered, he’s back to his favorite activities once again.
Woman sleeping on a couch holds her stomach, as if in pain
Health Lab
Long COVID-19 is linked to chronic pain conditions
Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID-19
vial of blood in container lab blue yellow grainy graphic
Health Lab
Unveiling potential diagnostic, treatment target for APS-related thrombocytopenia
Researchers at the University of Michigan Health have unveiled a new mechanism that drives thrombocytopenia and a potential clinically actionable biomarker for antiphospholipid syndrome associated thrombocytopenia.
Illustration of hand and enzymes that affect scleroderma patients
Health Lab
Novel antibody targets CD38 enzyme to treat systemic sclerosis
New study has identified an enzyme contributing to systemic sclerosis.
Paxlovid pill green Covid medicine
Health Lab
A how-to guide to COVID treatments
A Michigan Medicine FAQ about Paxlovid, with new information since its FDA approval in May 2023.